The mystery of why mycobacteria—a family that includes the microbe that causes TB—are extraordinarily hardy organisms is being unravelled by University of Otago, New Zealand, research that offers new hope for developing a revolutionary class of antibiotics to tackle TB.
In collaboration with researchers in the US and Germany, Otago microbiologists have teased out the mechanisms by which the aerobic soil microbe Mycobacterium smegmatis is able to persist for extreme lengths of time in the absence, or near-absence, of oxygen.